Search
Close this search box.
RESEARCH & THOUGHTS

Perspectives Shaping Clinical Development

Discover engaging resources driving the conversation forward and on-demand demo videos showcasing the very solutions forming the future of our field.

Examining the Current State of ICH E6 (R2) Adoption
Over the last few years, CluePoints has hosted a series of events in conjunction with TUFTS Center for...
Download
From RBM to RBQM: The Future of Risk-Based Trial Management
With the abundance of in-depth resources available; FDA, ICH guidance etc., it’s understandable...
Download
Harnessing CSM to Drive Risk-Based Quality Management (RBQM)
In terms of managing trial risks effectively, the FDA and ICH guidance documents contain clear expectations...
Download
Conclusions from Executive Roundtable on Response to ICH E6 (R2)
Over the last few years, CluePoints has hosted a series of events in conjunction with TUFTS Center for...
Download
Implementing a Scalable Risk-Based Monitoring Strategy
What’s Covered in the Guide? The importance of Risk-Based Monitoring/ Risk-Based Quality Management...
Download
Sponsor Responses to the ICH E6 Revisions
Learn about how companies are responding to the addendum.
Download
1 6 7 8 9 10 26
10 Ways The Pandemic Changed CluePoints
Does Central Monitoring Lead To Higher Quality? An Analysis Of KRI Outcomes
10 Ways Mid-Sized BioPharma Has Applied A Pragmatic Approach To RBQM Implementation
FDA Places Quality Management At The Heart Of Updated Inspection Guide
CluePoints Co-Founder And Chief Executive Officer To Speak At SCOPE Europe
臨床試験の分散化:障壁緩和と導入への推進
Decentralized Clinical Trials: Alleviating Barriers And Driving Adoption
10 Considerations For Small Biotechs Looking To Implement RBQM
Understanding Trends In QTL Adoption
UK’s MHRA Cites CluePoints Centralized Statistical Monitoring In Updated GCP Guidance
Risk-Based Fraud Detection: How Centralized Monitoring Can Boost Data Quality
Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring
None found. Please check back later!
None found. Please check back later!
None found. Please check back later!
None found. Please check back later!
Is It Too Soon To Define Best Practice When It Comes To The Practical Implementation Of Risk-Based Monitoring?
Risk-Based Monitoring Insights From The Industry: Craig Serra
RACT Clinical Trials: How To Deploy Risk Assessment Categorization Effectively
Transcelerate’s Latest Paper – “Detecting Data Quality Issues In Clinical Trials: Current Practices And Recommendations”
Want Full Control Of Your Risk-Based Monitoring Analyses?
The Evolution Of CluePoints’ SMART Engine
CluePoints’ Commentary – EMA Reflection Paper On Risk Based Quality Management In Clinical Trials
A CluePoints Case Study: Confirmation Of Fraud – Diaries Completed By Staff
Risk-Based Management And The Difference Between Key Risk Indicators And Central Statistical Monitoring
New FDA Guidance Encourages Sponsors To Use Centralized Statistical Monitoring For Improved Data Quality
Is Risk-Based Monitoring The Answer To Data Quality Issues?
CluePoints Launches Powerful & Pragmatic Solution To Risk-Based Monitoring
None found. Please check back later!
None found. Please check back later!
None found. Please check back later!